X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (53) 53
diabetes (38) 38
male (35) 35
animals (32) 32
humans (28) 28
endocrinology & metabolism (27) 27
insulin (22) 22
rats (20) 20
diabetis (19) 19
glucose (19) 19
mice (18) 18
apoptosis (17) 17
abridged index medicus (15) 15
transplantation (14) 14
blood glucose - metabolism (13) 13
female (13) 13
b cells (12) 12
cèl·lules b (12) 12
diabetes mellitus (12) 12
insulin-secretion (12) 12
islets of langerhans transplantation (12) 12
type 2 diabetes (12) 12
illots de langerhans (11) 11
metformin (11) 11
insulin-secreting cells - metabolism (10) 10
insulina (10) 10
islands of langerhans (10) 10
islets of langerhans - pathology (10) 10
mice, inbred c57bl (10) 10
middle aged (10) 10
pancreatic beta cells (10) 10
diabetes mellitus, type 2 - drug therapy (9) 9
hyperglycemia (9) 9
hypoglycemic agents - therapeutic use (9) 9
islets of langerhans - metabolism (9) 9
pancreas (9) 9
physiological aspects (9) 9
physiology (9) 9
research (9) 9
cell proliferation (8) 8
diabetes mellitus, experimental - surgery (8) 8
gene expression (8) 8
insulin - metabolism (8) 8
islet transplantation (8) 8
liraglutide (8) 8
rats, inbred lew (8) 8
time factors (8) 8
diabetics (7) 7
glucagon-like peptide 1 - analogs & derivatives (7) 7
glucosa (7) 7
insulin secretion (7) 7
insulin-secreting cells - cytology (7) 7
islets of langerhans - cytology (7) 7
mass (7) 7
medicine, research & experimental (7) 7
regeneration (7) 7
treatment outcome (7) 7
adult (6) 6
aged (6) 6
beta-cell mass (6) 6
cell & tissue engineering (6) 6
cells, cultured (6) 6
fisiologia (6) 6
glucagon-like peptide 1 - therapeutic use (6) 6
glucose - pharmacology (6) 6
glycosylated hemoglobin (6) 6
insulin-secreting cells - drug effects (6) 6
langerhans (6) 6
pancreatic-islets (6) 6
research article (6) 6
surgery (6) 6
transplantation, isogeneic (6) 6
beta cell mass (5) 5
beta-cell replication (5) 5
care and treatment (5) 5
drug-eluting stents (5) 5
gastrin (5) 5
glucagon-like peptide 1 - adverse effects (5) 5
glycated hemoglobin a - metabolism (5) 5
health aspects (5) 5
hypoglycemic agents - adverse effects (5) 5
in-vitro (5) 5
insulin resistance (5) 5
insulin-secreting cells - physiology (5) 5
internal medicine (5) 5
metabolism (5) 5
metformina (5) 5
pancreatectomy (5) 5
pàncrees (5) 5
rat (5) 5
risk (5) 5
secretion (5) 5
stem cells (5) 5
cell biology (4) 4
cell division (4) 4
clinical medicine (4) 4
dextrose (4) 4
diabetes mellitus, experimental - metabolism (4) 4
diabetes therapy (4) 4
differentiation (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9683, pp. 39 - 47
Summary Background Unlike most antihyperglycaemic drugs, glucagon-like peptide-1 (GLP-1) receptor agonists have a glucose-dependent action and promote weight... 
Internal Medicine | NON-INFERIORITY | METFORMIN | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | SULFONYLUREA | GLUCAGON-LIKE PEPTIDE-1 | HUMAN GLP-1 ANALOG | BETA-CELL MASS | TREATED PATIENTS | ACUTE-PANCREATITIS | INSULIN GLARGINE | Nausea - chemically induced | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Glycated Hemoglobin A - drug effects | Male | Diabetes Mellitus, Type 2 - metabolism | Weight Loss - drug effects | Dose-Response Relationship, Drug | Glucagon-Like Peptide 1 - agonists | Injections, Subcutaneous | Female | Hypoglycemia - chemically induced | Hypoglycemic Agents - therapeutic use | Drug Administration Schedule | Peptides - chemistry | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glucagon-Like Peptide 1 - chemistry | Linear Models | Logistic Models | Treatment Outcome | Hypoglycemic Agents - chemistry | Blood Glucose - drug effects | Analysis of Variance | Venoms - therapeutic use | Venoms - chemistry | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Hypoglycemic agents | Dosage and administration | Drug therapy | Molecular structure | Clinical trials | Diabetes | Clinical medicine | Apoptosis | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Nature Genetics, ISSN 1061-4036, 03/2010, Volume 42, Issue 3, pp. 255 - 259
Journal Article
Diabetes, ISSN 0012-1797, 03/2014, Volume 63, Issue 3, pp. 832 - 834
Journal Article
ISSN 0012-1797, 03/2014
The global epidemic of type 2 diabetes is largely secondary to insulin resistance induced by obesity and sedentary lifestyles. Most insulin-resistant subjects... 
Resistència a la insulina | Islands of Langerhans | Insulin resistance | Illots de Langerhans
Journal Article
Diabetes, ISSN 0012-1797, 05/2016, Volume 65, Issue 5, pp. 1155 - 1157
Stem cells represent an unlimited source for cell therapy (1), and considerable efforts have been made to overcome barriers to introducing this revolutionary... 
Index Medicus | Abridged Index Medicus | Teràpia cel·lular | Diabetes | Diabetis | Cèl·lules mare | Stem cells | Cellular therapy
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2018, Volume 13, Issue 1, pp. e0191104 - e0191104
Journal Article
Diabetes Care, ISSN 0149-5992, 06/2010, Volume 33, Issue 6, pp. 1300 - 1303
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 17515 - 10
Journal Article
Journal of Clinical Periodontology, ISSN 0303-6979, 02/2018, Volume 45, Issue 2, pp. 138 - 149
BackgroundDiabetes and periodontitis are chronic non-communicable diseases independently associated with mortality and have a bidirectional relationship.... 
chronic kidney disease | type 1 diabetes | complications | association | diabetes mellitus | periodontal disease | type 2 diabetes | retinopathy | gestational diabetes | periodontitis | mortality | nephropathy | intervention | HbA1c | incident | mechanisms | RISK | MELLITUS | IMPACT | DENTISTRY, ORAL SURGERY & MEDICINE | HEALTH | Glycated Hemoglobin A - analysis | Periodontal Diseases - complications | Periodontal Diseases - therapy | Periodontal Diseases - etiology | Periodontal Diseases - diagnosis | Humans | Insulin Resistance | Diabetes Mellitus, Type 1 - complications | Diabetes Mellitus, Type 1 - therapy | Periodontitis - etiology | Diabetes Mellitus, Type 1 - diagnosis | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 1 - etiology | Diabetes Mellitus, Type 2 - therapy | Diabetes Mellitus, Type 2 - etiology | Periodontitis - complications | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Diabetic retinopathy | Diabetics | Workshops (Educational programs) | Communicable diseases | Mortality | Glycosylated hemoglobin | Practice guidelines (Medicine) | Epidemiology | Periodontal disease | Conferences, meetings and seminars | Interleukins | Chronic kidney failure | Type 1 diabetes | Insulin resistance | Health aspects | Oxidative stress | NF-κB protein | Diabetes mellitus | Diabetes mellitus (insulin dependent) | Insulin | Osteoprotegerin | Periodontal diseases | Interleukin 6 | Periodontitis | Tumor necrosis factor | Interleukin 1 | Hemoglobin | Toll-like receptors | Diabetes | Diabetes mellitus (non-insulin dependent) | Tumors | Index Medicus | Dentistry
Journal Article